UBE2C and plasma cell myeloma: As aforementioned, recently, Xi and colleagues demonstrated, for the first time, that UbcH10 is highly expressed in three bortezomib (BTZ)-resistant multiple myeloma cell lines, which is attributed to the inactivation of post-transcriptional control.